Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.


TSX:SVA - Post by User

Comment by Mercuryfilling1on Jan 07, 2022 4:39pm
278 Views
Post# 34294659

RE:Incompetence arrives on The Most Inopportune Day

RE:Incompetence arrives on The Most Inopportune DayTwo things, SF. 
He’s not a doctor, he’s a Doug (but forgive me, maybe that’s your attempt at humour?)…and SVA didn’t put out a NR about Dougie’s call, the Globe & Mail did that.
Also, lots of investors here took this week’s surge as an opportunity to pare back (5% in my case) just in case Monday isn’t the “come to Jesus” moment we’ve all been waiting for. I hope it is, but based on previous history, many prefer to exercise caution and lock in some profits. 
That’s the reason the share price is hovering below $2.20, not because there’s some guy who says consensus on the street is $2.50. What consensus and which street? The Yellow Brick Road starring Dougie as the Straw Man?
Have to agree with Bio on this. Groan.
<< Previous
Bullboard Posts
Next >>